123 related articles for article (PubMed ID: 3133934)
1. [Effects of etidronate disodium (EHDP) on urogenital malignancies with bone metastasis: a multicentered collaborative evaluation].
Kawamura J; Tochigi H; Yanagawa M; Yoshida O; Hida S; Mori O; Suzuki N; Saito K; Komatsu Y; Hatayama T
Hinyokika Kiyo; 1988 Mar; 34(3):528-37. PubMed ID: 3133934
[TBL] [Abstract][Full Text] [Related]
2. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
[TBL] [Abstract][Full Text] [Related]
3. Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy.
Hommeyer SH; Varney DM; Eary JF
J Nucl Med; 1992 May; 33(5):748-50. PubMed ID: 1569485
[TBL] [Abstract][Full Text] [Related]
4. Duration of etidronate effect demonstrated by serial bone scintigraphy.
Sandler ED; Parisi MT; Hattner RS
J Nucl Med; 1991 Sep; 32(9):1782-4. PubMed ID: 1908891
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
[TBL] [Abstract][Full Text] [Related]
6. Effect of etidronate disodium on the development of bone lesions in an animal model of bone metastasis using the human prostate cancer cell line PC-3.
Shevrin DH; Gorny KI; Rosol TJ; Kukreja SC
Prostate; 1991; 19(2):149-54. PubMed ID: 1923962
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
Rashid M; Khairi A; Johnston C
Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
[No Abstract] [Full Text] [Related]
8. Effects of disodium etidronate in murine tumor models.
Guaitani A; Polentarutti N; Filippeschi S; Marmonti L; Corti F; Italia C; Coccioli G; Donelli MG; Mantovani A; Garattini S
Eur J Cancer Clin Oncol; 1984 May; 20(5):685-93. PubMed ID: 6428894
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
Stein I; Shapiro B; Ostrum B; Beller ML
Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
[TBL] [Abstract][Full Text] [Related]
11. False-negative bone imaging due to etidronate disodium therapy.
Krasnow AZ; Collier BD; Isitman AT; Hellman RS; Ewey D
Clin Nucl Med; 1988 Apr; 13(4):264-7. PubMed ID: 3131057
[TBL] [Abstract][Full Text] [Related]
12. Diphosphonate therapy of paget's disease of bone.
Canfield R; Rosner W; Skinner J; McWhorter J; Resnick L; Feldman F; Kammerman S; Ryan K; Kunigonis M; Bohne W
J Clin Endocrinol Metab; 1977 Jan; 44(1):96-106. PubMed ID: 401827
[TBL] [Abstract][Full Text] [Related]
13. Treatment of painful prostatic bone metastases with oral etidronate disodium.
Carey PO; Lippert MC
Urology; 1988 Nov; 32(5):403-7. PubMed ID: 2460988
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).
Alexandre CM; Chapuy MC; Vignon E; Edouard C; Johnston CC; Meunier PJ
Clin Orthop Relat Res; 1983 Apr; (174):193-205. PubMed ID: 6403270
[TBL] [Abstract][Full Text] [Related]
15. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
[TBL] [Abstract][Full Text] [Related]
16. A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodium.
Nemoto R; Uchida K; Tsutsumi M; Koiso K; Satou S; Satou T
J Cancer Res Clin Oncol; 1987; 113(6):539-43. PubMed ID: 3119600
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of bone turnover in patients with bone metastasis of various cancer of urogenital tract].
Takenaka I; Miyagawa I; Kunitomi K; Hirakawa S; Matsuoka N; Kawamura H
Nihon Hinyokika Gakkai Zasshi; 1990 Aug; 81(8):1190-6. PubMed ID: 2232410
[TBL] [Abstract][Full Text] [Related]
18. Transient relief of metastatic cancer bone pain by oral administration of etidronate.
Iwamoto J; Takeda T; Ichimura S
J Bone Miner Metab; 2002; 20(4):228-34. PubMed ID: 12115069
[TBL] [Abstract][Full Text] [Related]
19. Effect of daily etidronate on the osteolysis of multiple myeloma.
Belch AR; Bergsagel DE; Wilson K; O'Reilly S; Wilson J; Sutton D; Pater J; Johnston D; Zee B
J Clin Oncol; 1991 Aug; 9(8):1397-402. PubMed ID: 1712835
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
